Jin Sheng Selected Research

Jin Sheng Research Topics

Disease

16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2014
12	Neoplasms (Cancer) 01/2022 - 07/2009
2	Myocardial Infarction 05/2019 - 05/2015
2	Nasopharyngeal Carcinoma 01/2018 - 10/2016
2	Necrosis 08/2016 - 07/2009
2	Huntington Disease (Huntington's Disease) 01/2013 - 12/2006
1	Hyperplasia 04/2022
1	Pathologic Constriction (Stenosis) 04/2022
1	Thrombosis (Thrombus) 04/2022
1	Arteriosclerosis 04/2022
1	Disease Progression 01/2021
1	Shock 05/2019
1	Adenocarcinoma of Lung 09/2017
1	Death (Near-Death Experience) 01/2017
1	Cardiomyopathies (Cardiomyopathy) 01/2017
1	Nausea 01/2017
1	Vomiting 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2016
1	Exanthema (Rash) 04/2016
1	Diarrhea 04/2016
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2016
1	Infarction (Infarctions) 05/2015
1	Stroke (Strokes) 01/2013
1	Amyloid Plaque 01/2013
1	Cognitive Dysfunction 01/2013
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Alzheimer Disease (Alzheimer's Disease) 01/2013
1	Hypoxia (Hypoxemia) 01/2013
1	Osteosarcoma (Osteogenic Sarcoma) 07/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2006

Drug/Important Bio-Agent (IBA)

7	ErbB Receptors (EGF Receptor)IBA 08/2016 - 01/2014
4	Tyrosine Kinase InhibitorsIBA 08/2016 - 01/2014
3	Gefitinib (Iressa)FDA Link 01/2017 - 04/2016
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 10/2016
2	Proteins (Proteins, Gene)FDA Link 10/2016 - 03/2016
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 08/2016 - 04/2016
2	Cytotoxins (Cytolysins)IBA 08/2015 - 01/2015
2	Angiogenesis InhibitorsIBA 08/2015 - 01/2015
2	ProdrugsIBA 01/2013 - 12/2006
2	UridineIBA 01/2013 - 12/2006
2	uridine triacetateIBA 01/2013 - 12/2006
1	MetalsIBA 04/2022
1	CholesterolIBA 04/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	atezolizumabIBA 01/2021
1	Anaplastic Lymphoma KinaseIBA 10/2019
1	pembrolizumabIBA 09/2017
1	Immune Checkpoint InhibitorsIBA 09/2017
1	Neurokinin-1 Receptor AntagonistsIBA 01/2017
1	CytokinesIBA 01/2017
1	Messenger RNA (mRNA)IBA 10/2016
1	Cisplatin (Platino)FDA LinkGeneric 10/2016
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 10/2016
1	Thymidylate SynthaseIBA 10/2016
1	Indicators and Reagents (Reagents)IBA 08/2016
1	vandetanib (ZD6474)IBA 08/2016
1	AfatinibIBA 04/2016
1	Transaminases (Aminotransferases)IBA 04/2016
1	AlbuminsIBA 03/2016
1	GlobulinsIBA 03/2016
1	NivolumabIBA 01/2016
1	Monoclonal AntibodiesIBA 08/2015
1	Taxoids (Taxanes)IBA 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013
1	Neuroprotective AgentsIBA 01/2013
1	Mitochondrial DNA (mtDNA)IBA 01/2013
1	tetra-4-amidinophenoxypropane (TAPP)IBA 01/2013
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2013
1	CeramidesIBA 01/2013
1	Amyloid (Amyloid Fibrils)IBA 01/2013
1	Capsules (Microcapsules)IBA 07/2009
1	Coloring Agents (Dyes)IBA 07/2009
1	3-nitropropionic acidIBA 12/2006

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2017 - 07/2009
6	Therapeutics 01/2022 - 01/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2022
1	Immunotherapy 12/2020
1	Percutaneous Coronary Intervention 05/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Neoadjuvant Therapy 01/2016
1	Ligation 05/2015
1	Thoracotomy 05/2015
1	Limb Salvage 07/2009